alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
PART II       OTHER INFORMATION


Item 6.    Exhibits and Reports on Form 8-K

(a)   Exhibits-

      Exhibit-27 Financial Data Schedule is filed with this 10-Q/A.


                                                             
                                                             
                                                             
             THE KRYSTAL COMPANY AND SUBSIDIARY              
             ----------------------------------              
                        SIGNATURES                           
                        ----------                           
Pursuant to the requirements of the Securities Exchange Act 
of 1934, the registrant has duly caused this report to be 
signed on its behalf by the undersigned thereunto duly 
authorized.                                                
                                                           
                                                           
                                                           
                                                           
                         THE KRYSTAL COMPANY               
                         (Registrant)                      
                                                           
Dated: 11/4/96            Camden B. Scearce               
--------------           ------------------------          
                         Camden B. Scearce                 
                        (Vice President and Chief Financial
                         and Accounting Officer)
[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Page 37887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17040]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Clinical Trial Planning Grant 
(R34), Implementation Cooperative Agreement (U01) and SBIR Phase II 
Implementation Cooperative Agreement (U44).
    Date: September 12, 2017.
    Time: 10:00 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review 
Officer Scientific Review Program Division of Extramural Activities, 
National Institutes of Health/NIAID, 5601 Fishers Lane, Rockville, 
MD 20852, 240-669-5026, <a href="/cdn-cgi/l/email-protection#315950435843585c57715f585058551f5f58591f565e47"><span class="__cf_email__" data-cfemail="2941485b405b40444f69474048404d07474041074e465f">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 8, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17040 Filed 8-11-17; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
IV 

108TH CONGRESS 

1ST SESSION H. RES. 332

Amending the Rules of the House of Representatives to apply the layover 

requirements for conference reports during the last six days of a session 

of Congress, to require that certain matter be included in joint explanatory statements accompanying conference reports, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 23, 2003

Mr. ISAKSON submitted the following resolution; which was referred to the 

Committee on Rules 

RESOLUTION

Amending the Rules of the House of Representatives to 

apply the layover requirements for conference reports 

during the last six days of a session of Congress, to 

require that certain matter be included in joint explanatory statements accompanying conference reports, and 

for other purposes.

1 Resolved, That (a) clause 8(a) of rule XXII of the 

2 Rules of the House of Representatives (relating to layover 

3 requirements for conference reports) is amended by strik4 ing ‘‘(1) Except as specified in subparagraph (2), it’’ and 

5 inserting ‘‘It’’ and by striking subparagraph (2). 
2

•HRES 332 IH 

1 (b) Clause 8(b) of rule XXII of the Rules of the 

2 House of Representatives (relating to layover require3 ments for amendments in disagreement) is amended by 

4 striking ‘‘(1) Except as specified in subparagraph (2), it’’ 

5 and inserting ‘‘It’’ and by striking subparagraph (2). 

6 (c) Clause 6(a)(2) of rule XIII of the Rules of the 

7 House of Representatives (relating to privileged reports by 

8 the Committee on Rules) is amended by striking ‘‘or of 

9 clause 8’’. 

10 (d) Rule XXII of the Rules of the House of Rep11 resentatives (relating to House and Senate relations) is 

12 amended by adding at the end the following new clause: 

13 ‘‘13. It shall not be in order to consider a conference re14 port to accompany a bill or joint resolution making or con15 tinuing appropriations unless—

16 ‘‘(1) the joint explanatory statement of the 

17 managers includes a separate part that clearly sets 

18 forth each item of appropriation added by the com19 mittee of conference to fund a new program, project, 

20 or activity and the program, project, or activity to 

21 which it relates; or 

22 ‘‘(2) the chairman of the Committee on Appro23 priations causes such matter to be printed in the 
3

•HRES 332 IH 

1 Congressional Record before consideration of the 

2 conference report.’’.

Æ
**Exhibit 32.1****CERTIFICATION OF CHIEF EXECUTIVE OFFICER****Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)**     The undersigned executive officer of Anchor BanCorp Wisconsin Inc. (the “Registrant”)hereby certifies that the Registrant’s Form 10-Q for the three months ended December 31, 2006 fullycomplies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that theinformation contained therein fairly presents, in all material respects, the financial conditionand results of operations of the Registrant.                                                      /s/ Douglas J. Timmerman   Douglas J. Timmerman, Chairman of the Board, Presidentand Chief Executive Officer   February 5, 2007**Note:**A signed original of this written statement required by Section 906 of theSarbanes-Oxley Act of 2002 has been provided to Anchor BanCorp Wisconsin Inc. and will be retainedby Anchor BanCorp Wisconsin Inc. and furnished to the Securities and Exchange Commission or itsstaff upon request.
45
EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES–OXLEY ACT OF 2002

        I, Philippe Lemaitre, certify that:

        (1)  I have reviewed this annual report on Form 10-K for the period ending September 27, 2003;

        (2)  Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

        (3)  Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

        (4)  The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) for the registrant and have:

        (a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

        (b)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation; and

        (c)  Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

        (5)  The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

        (a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

        (b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
**Exhibit 31.2**

** **

**Certification of the ChiefFinancial Officer**

(Pursuant to Rule13a-14(a))

 

I, Gary Williams, certify that:

 

1.               I have reviewed this Form 10-Q of Focus Enhancements,Inc.;

2.               Based on my knowledge, this report does not containany untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

3.               Based on my knowledge, the financial statements, andother financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flowsof the registrant as of, and for, the periods presented in this report;

4.               The registrant’s other certifying officer and I areresponsible for establishing and maintaining disclosure controls and procedures(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrantand have:

(a) Designed such disclosure controls and procedures,or caused such disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to the registrant,including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is beingprepared;

(b) Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as of theend of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarterin the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financialreporting; and

5.               The registrant’s other certifying officer and I havedisclosed, based on our most recent evaluation of internal control overfinancial reporting, to the registrant’s auditors and the audit committee ofthe registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’sinternal control over financial reporting.

 

Date: November 14, 2007

 
|   | /s/  | Gary Williams              |   |
|--------|-----------|---------------------------------|--------|
|   |      | Gary Williams                   |   |
|   |      | Executive VP of Finance and CFO |

 

 

 

----
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-02-2000
<PERIOD-START>                             JAN-04-1999
<PERIOD-END>                               APR-04-1999
<CASH>                                            8480
<SECURITIES>                                         0
<RECEIVABLES>                                     1092
<ALLOWANCES>                                         0
<INVENTORY>                                       1502
<CURRENT-ASSETS>                                 14398
<PP&E>                                          117390
<DEPRECIATION>                                   18427
<TOTAL-ASSETS>                                  176338
<CURRENT-LIABILITIES>                            22965
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         35000
<OTHER-SE>                                        1281
<TOTAL-LIABILITY-AND-EQUITY>                    176338
<SALES>                                          63248
<TOTAL-REVENUES>                                 65647
<CGS>                                            51604
<TOTAL-COSTS>                                    51604
<OTHER-EXPENSES>                                   794
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                2545
<INCOME-PRETAX>                                   1137
<INCOME-TAX>                                       662
<INCOME-CONTINUING>                                475
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       475
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0

        

</TABLE>
Instrument of Transfer - GM Investment Company Ltd. and China Bright



 Exhibit 10.52 
 INSTRUMENT OF TRANSFER 
  

			
	NAME OF COMPANY:	  	Pypo Digital Company Limited
		  	(incorporated in the Cayman Islands with limited liability)
		  	

  

			
	I, the Transferor,	  	GM Investment Company Limited
	of:	  	48th Floor, Bank of China Tower,
		  	1 Garden Road, Central, Hong Kong.
		
	in consideration of:	  	US$0.05

  

			
	do hereby transfer to Transferee:	  	China Bright Group Co. Limited
	Occupation/Description:	  	Corporation
	of:	  	48th Floor, Bank of China Tower,
		  	1 Garden Road, Central, Hong Kong.

 (the “Transferee”) do hereby transfer to the Transferee the 500 Shares of par value of US$0.0001
each, standing in my/our name in the Register of the above company to hold unto the Transferee, his executors, administrators or assigns, subject to the several conditions upon which I/we hold the same at the time of execution hereof. 
 I/We, the Transferee, do hereby agree to take the said Share(s) subject to the same conditions. 
 Dated: 12 October 2007 
  

									
	witness to signature of Transferor	 		 	
	Name:	 	KONG KAM YU	 		 	
	Address:	 	48/F Bank of China Tower	 		 	
		 	1 Garden Road,	 		 	
		 	Central, Hong Kong	 		 	
			
	/s/ Kong Kam Yu	 		 	/s/ KAM Yuen
	Signature of Witness	 		 	 signature of Transferor
 for and on
behalf of GM Investment Company Limited


  

									
	witness to signature of Transferee	 		 	
	Name:	 	KONG KAM YU	 		 	
	Address:	 	48/F Bank of China Tower	 		 	
		 	1 Garden Road,	 		 	
		 	Central, Hong Kong	 		 	
			
	/s/ Kong Kam Yu	 		 	/s/ KAM Yuen
	Signature of Witness	 		 	 signature of Transferor
 for and on
behalf of China Bright Group Co. Limited
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                              50
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                  2,719,123
<CURRENT-ASSETS>                             2,719,173
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               2,719,173
<CURRENT-LIABILITIES>                           94,527
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   2,624,646
<TOTAL-LIABILITY-AND-EQUITY>                 2,719,173
<SALES>                                              0
<TOTAL-REVENUES>                                     3
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      3
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  3
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         3
<EPS-PRIMARY>                                     0.00
<EPS-DILUTED>                                     0.00
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                             480
<SECURITIES>                                         0
<RECEIVABLES>                                   37,280
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                37,760
<PP&E>                                       4,939,913
<DEPRECIATION>                               2,853,917
<TOTAL-ASSETS>                               2,123,756
<CURRENT-LIABILITIES>                           10,412
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 2,123,756
<SALES>                                        210,609
<TOTAL-REVENUES>                               214,780
<CGS>                                           83,370
<TOTAL-COSTS>                                  157,724
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 57,056
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             57,056
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    57,056
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
|   Name of Subsidiary                                                            |  Jurisdictionof Incorporation | YearAcquiredof Formed | Percentageof VotingSecurities Owned |
|-------------------------------------------------------------------------------------------|------------------------------------|-----------------------|-------------------------------------|
| ASI Data Services Inc                                                                     | Maine                         | 1993             | 100%                           |
| Northeast Bank (and its 100% owned subsidiary, Northeast Bank Insurance Group, Inc.) | Maine                              | 1987                  | 100%                                |
Exhibit 99.2

                Written Statement of the Chief Financial Officer
                       Pursuant to 18 U.S.C. Section 1350

         Solely for the purposes of complying  with 18 U.S.C.  Section  1350, I,
the undersigned  Senior Vice President and Chief Financial Officer of Winn-Dixie
Stores, Inc. (the "Company"),  hereby certify,  based on my knowledge,  that the
Annual  Report on Form 10-K of the Company for the year ended June 26, 2002 (the
"Report")  fully  complies  with  the  requirements  of  Section  13(a)  of  the
Securities  Exchange  Act of 1934 and that  information  contained in the Report
fairly presents,  in all material respects,  the financial condition and results
of operations of the Company.



/s/      Richard P. McCook
   ------------------------
         Richard P. McCook
         August 7, 2002
| 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended,; and |
|----|------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

| Date: May 12, 2010 |   |                          |
|--------------------|--------|-------------------------------|
|               |   |                          |
|               |   | /s/ Gil Allon                 |   |
|               |   | Gil Allon                     |
|               |   | Chief Executive Officer       |
|               |   | (Principal Executive Officer) |
|               |   |                          |
|               |   |                          |
|               |   |                          |
|               |   |                          |
|               |   | /s/ Ariel Shenhar        |   |
|               |   | Ariel Shenhar                 |
|               |   | Chief Financial Officer       |
|               |   | (Principal Financial Officer) |